Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF June 30, 2017 | Archived Issues

Meetings and Events


Grand Rounds


Upcoming CME Conferences


Milestones

Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue.

Submit your milestones and comments.

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Core Labs Changing Ketone Testing in July

The Core laboratories in the Department of Pathology and Laboratory Medicine will be switching ketone testing to Precision Xceed Pro Monitor instruments from Abbott Diabetes Care Ltd. beginning Tuesday, July 25.

Specifically, beta-hydroxybutyrate (BHB), the dominant ketone body produced in fasting states and diabetic ketoacidosis, will be quantitatively measured in whole blood. Measurement of BHB will replace qualitative testing for aceotoacetate via Acetest™ tablets (in serum and urine).

Manufacture of Acetest Reagent has been discontinued. The change offers in improvement in the detection of ketoacidosis due to the quantitative nature of the replacement test and the fact that BHB is the dominant ketone (BHB/acetoacetate ratio is approximately 3:1 to 7:1 in severe ketotic states).

Additionally, acetoacetate is relatively rapidly converted to beta-hydroxybutyrate, which means Acetest is subject to false negative results.

Only whole blood samples will be acceptable on the new BHB assay. The reference cutoff for BHB: <0.6 mol/L

If you have questions, please contact Kimia Sobhani, PhD, at kimia.sobhani@cshs.org.